EP1409523A4 - Acides nucleiques et polypeptides pancam - Google Patents

Acides nucleiques et polypeptides pancam

Info

Publication number
EP1409523A4
EP1409523A4 EP02756316A EP02756316A EP1409523A4 EP 1409523 A4 EP1409523 A4 EP 1409523A4 EP 02756316 A EP02756316 A EP 02756316A EP 02756316 A EP02756316 A EP 02756316A EP 1409523 A4 EP1409523 A4 EP 1409523A4
Authority
EP
European Patent Office
Prior art keywords
pancam
polypeptides
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02756316A
Other languages
German (de)
English (en)
Other versions
EP1409523A2 (fr
Inventor
Chao Sun
John P Carulli
Alexander V Lukashin
Daniel R Kilburn
Humphrey Athelstan Roy Gardner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/019904 external-priority patent/WO2001098360A2/fr
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of EP1409523A2 publication Critical patent/EP1409523A2/fr
Publication of EP1409523A4 publication Critical patent/EP1409523A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP02756316A 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam Withdrawn EP1409523A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/US01/19904 2001-06-22
PCT/US2001/019904 WO2001098360A2 (fr) 2000-06-22 2001-06-22 Acides nucleiques et polypeptides de gp354
PCT/US2002/020275 WO2003000021A2 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam

Publications (2)

Publication Number Publication Date
EP1409523A2 EP1409523A2 (fr) 2004-04-21
EP1409523A4 true EP1409523A4 (fr) 2005-06-15

Family

ID=21742663

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02756316A Withdrawn EP1409523A4 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam

Country Status (5)

Country Link
EP (1) EP1409523A4 (fr)
JP (1) JP4224395B2 (fr)
AU (1) AU2002322331B2 (fr)
CA (2) CA2451271A1 (fr)
WO (1) WO2003000021A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650380A1 (fr) * 2006-04-28 2007-11-08 Oregon Health & Science University Anticorps monoclonaux et leur utilisation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025497A1 (fr) * 1995-02-17 1996-08-22 Incyte Pharmaceuticals, Inc. Nouvelles chemokines exprimees dans le pancreas
WO1998036062A1 (fr) * 1997-02-13 1998-08-20 Smithkline Beecham Plc Variantes d'epissage de molecule d'adherence cellulaire neuronale
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025497A1 (fr) * 1995-02-17 1996-08-22 Incyte Pharmaceuticals, Inc. Nouvelles chemokines exprimees dans le pancreas
WO1998036062A1 (fr) * 1997-02-13 1998-08-20 Smithkline Beecham Plc Variantes d'epissage de molecule d'adherence cellulaire neuronale
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, Hinxton, UK; 11 June 1997 (1997-06-11), LAMERDIN J E ET AL: "Sequence analysis of a 1 Mb region in 19q13.1", XP002212520, Database accession no. AC002133 *
DATABASE EMBL [online] EBI, Hinxton, UK; 31 January 2000 (2000-01-31), ABOLA A P ET AL: "Homo sapiens chromosome 19 clone RP11-38C1", XP002212519, Database accession no. AC022315 *
DATABASE EMBL [online] EBI, Hinxton, UK; 5 January 2001 (2001-01-05), DUESTERHOEFT A ET AL: "Homo sapiens mRNA", XP002212521, Database accession no. AL136654 *
RAMOS RICARDO G P ET AL: "The Irregular chiasm C-roughest locus of Drosophila, which affects axonal projections and programmed cell death, encodes a novel immunoglobulin-like protein.", GENES & DEVELOPMENT, vol. 7, no. 12B, 1993, pages 2533 - 2547, XP008007783, ISSN: 0890-9369 *
VAN SCHILFGAARDE R ET AL: "Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets.", JOURNAL OF MOLECULAR MEDICINE (BERLIN, GERMANY) JAN 1999, vol. 77, no. 1, January 1999 (1999-01-01), pages 199 - 205, XP002311896, ISSN: 0946-2716 *

Also Published As

Publication number Publication date
JP4224395B2 (ja) 2009-02-12
AU2002322331B2 (en) 2008-01-03
CA2459985A1 (fr) 2003-01-03
WO2003000021A3 (fr) 2003-11-20
EP1409523A2 (fr) 2004-04-21
CA2451271A1 (fr) 2003-01-03
WO2003000021A2 (fr) 2003-01-03
JP2005508147A (ja) 2005-03-31

Similar Documents

Publication Publication Date Title
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1556490A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2002256461A8 (en) Polypeptides and nucleic acids associated with cancer
AU2002367815A8 (en) Novel nucleic acids and secreted polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1383533A4 (fr) Proteines et acides nucleiques codant pour celles-ci
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
IL161765A0 (en) P85-alpha nucleic acids, polypeptides and related methods
AU7005801A (en) Gp354 nucleic acids and polypeptides
EP1274716A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040120

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7G 01N 33/53 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 12N 15/74 B

Ipc: 7C 12N 5/02 B

Ipc: 7C 12P 21/06 B

Ipc: 7C 07H 21/04 B

Ipc: 7C 07K 16/28 B

Ipc: 7C 07K 16/46 B

Ipc: 7C 07K 14/00 A

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GARDNER, HUMPHREY, ATHELSTAN, ROY

Inventor name: KILBURN, DANIEL, R.

Inventor name: LUKASHIN, ALEXANDER, V.

Inventor name: CARULLI, JOHN, P.

Inventor name: SUN, CHAO

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 38/17 B

Ipc: 7A 61K 31/7088 B

Ipc: 7G 01N 33/50 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 16/28 B

Ipc: 7C 07K 14/705 B

Ipc: 7C 12N 15/12 A

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1067370

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20050428

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOGEN IDEC MA INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090930

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1067370

Country of ref document: HK